(Q44864213)

6 December 2017

title

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception (English)

1 reference

6 December 2017

0 references

0 references

D J Mason

1

1 reference

6 December 2017

J Lowe

series ordinal

2

1 reference

6 December 2017

S P Welch

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

European Journal of Pharmacology

6 December 2017

published in

1 reference

6 December 2017

volume

378

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

237-248

1 reference

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Differential biotransformation of dynorphin A (1-17) and dynorphin A (1-13) peptides in human blood, ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal slice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Spinal dynorphin A (1-17): possible mediator of antianalgesic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

A series of novel, highly potent and selective agonists for the kappa-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

CI-977, a novel and selective agonist for the kappa-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Metabolism of dynorphin A1-13 in human CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Substance P is a possible neurotransmitter in the rat spinothalamic tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Processing of prodynorphin-derived peptides in striatal extracts. Identification by electrospray ionization mass spectrometry linked to size-exclusion chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Intracerebroventricular administration of beta-endorphin releases immunoreactive met-enkephalin from the spinal cord in cats, guinea pigs and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Kappa-opioid receptor modulation of the release of substance P in the dorsal horn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900479-3

10.1016/S0014-2999(99)00479-3

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference